AXL-associated tumor inflammation as a poor prognostic signature in chemotherapy-treated triple-negative breast cancer patients
Open Access
- 2 November 2016
- journal article
- research article
- Published by Springer Nature in npj Breast Cancer
- Vol. 2 (1) , 16033
Abstract
A subgroup of triple-negative breast cancer (TNBC) shows epithelial-to-mesenchymal transition (EMT) features, which are sustained by the interaction between cancer cells and tumor-associated macrophages (TAMs). In this study, the clinical relevance of 30 EMT-related kinases and the potential cross-talk with TAMs were investigated in a cohort of 203 TNBC patients treated with adjuvant chemotherapy. The prognostic value of the evaluated markers was validated in two independent cohorts of TNBC patients treated with adjuvant chemotherapy (N=95; N=137). In vitro, we investigated the potential synergism between cancer cells and TAMs. We found that the EMT-related kinase AXL showed the highest correlation with the frequency of CD163-positive macrophages (rS=0.503; PPPP=0.002; overall survival P=0.001). In vitro analysis demonstrated that AXL-expressing TNBC cells were able to polarize human macrophages towards an M2-like phenotype, and modulate a specific pattern of pro-tumor cytokines and chemokines. Selective AXL inhibition impaired the activity of M2-like macrophages, reducing cancer cell invasiveness, and restoring the sensitivity of breast cancer cells to chemotherapeutic drugs. These data suggest that the EMT-related kinase AXL overexpressed in cancer cells has prognostic significance, and contributes to the functional skewing of macrophage functions in TNBC. AXL inhibition may represent a novel strategy to target cancer cells, as well as tumor-promoting TAMs in TNBC.Keywords
This publication has 46 references indexed in Scilit:
- Mesenchymal Cancer Cell-Stroma Crosstalk Promotes Niche Activation, Epithelial Reversion, and Metastatic ColonizationCell Reports, 2015
- Macrophages and Therapeutic Resistance in CancerCancer Cell, 2015
- A Positive Feedback Loop between Mesenchymal-like Cancer Cells and Macrophages Is Essential to Breast Cancer MetastasisCancer Cell, 2014
- Regulatory networks defining EMT during cancer initiation and progressionNature Reviews Cancer, 2013
- Dissecting the Heterogeneity of Triple-Negative Breast CancerJournal of Clinical Oncology, 2012
- Tumor-associated macrophages regulate tumorigenicity and anticancer drug responses of cancer stem/initiating cellsProceedings of the National Academy of Sciences, 2011
- Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapiesJournal of Clinical Investigation, 2011
- Tumor-associated macrophages in breast cancer as potential biomarkers for new treatments and diagnosticsExpert Review of Molecular Diagnostics, 2011
- Molecular Stratification of Triple-Negative Breast CancersThe Oncologist, 2011
- Triple-Negative Breast CancerNew England Journal of Medicine, 2010